Literature DB >> 21420120

HIV status is an independent risk factor for reporting lower urinary tract symptoms.

Benjamin N Breyer1, Stephen K Van den Eeden, Michael A Horberg, Michael L Eisenberg, Donna Y Deng, James F Smith, Alan W Shindel.   

Abstract

PURPOSE: HIV/AIDS is a worldwide epidemic. Limited evidence suggests that men infected with HIV/AIDS are at increased risk for lower urinary tract symptoms. We determined whether HIV/AIDS status is an independent risk factor for self-reported bothersome lower urinary tract symptoms in a large contemporary cohort.
MATERIALS AND METHODS: We performed a cross-sectional, Internet based survey of urinary quality of life outcomes in adult HIV infected and HIV uninfected men who have sex with men. The main outcome measure was International Prostate Symptom Score.
RESULTS: Of respondents with complete data 1,507 were HIV uninfected (median age 42 years, mean 43) and 323 HIV infected (median age 45 years, mean 45.1). Of the HIV infected respondents 148 were nonAIDS defining HIV infected and 175 were AIDS defining HIV infected. After adjusting for age and other comorbid conditions, nonAIDS defining HIV infected and AIDS defining HIV infected status increased the odds of severe lower urinary tract symptoms by 2.07 (95% CI 1.04-3.79) and 2.49 (95% CI 1.43-4.33), respectively. HIV infected men had a worse total International Prostate Symptom Score for all domains including quality of life compared to HIV uninfected men. Within the population of men with HIV, those with AIDS had worse mean total International Prostate Symptom Score and all individual International Prostate Symptom Score components relative to nonAIDS defining HIV infected men.
CONCLUSIONS: HIV status is an independent risk factor for bothersome lower urinary tract symptoms. The odds of severe lower urinary tract symptoms are greater in HIV infected men with a history of AIDS.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21420120      PMCID: PMC3565615          DOI: 10.1016/j.juro.2010.12.043

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.

Authors:  M J Barry; W O Williford; F J Fowler; K M Jones; H Lepor
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

2.  Estimated future HIV prevalence, incidence, and potential infections averted in the United States: a multiple scenario analysis.

Authors:  H Irene Hall; Timothy A Green; Richard J Wolitski; David R Holtgrave; Philip Rhodes; J Stan Lehman; Teresa Durden; Kevin A Fenton; Jonathan H Mermin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

Review 3.  World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH.

Authors:  A T Cockett; Y Aso; L Denis; S Khoury; M Barry; C E Carlton; D Coffey; J Fitzpatrick; K Griffiths; T Hald
Journal:  Prog Urol       Date:  1991-12       Impact factor: 0.915

4.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

5.  Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study.

Authors:  G Welch; I Kawachi; M J Barry; E Giovannucci; G A Colditz; W C Willett
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

6.  Micturition disturbances and human immunodeficiency virus infection.

Authors:  J F Hermieu; V Delmas; L Boccon-Gibod
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

7.  Urinary tract infection in men with AIDS.

Authors:  A M De Pinho; G S Lopes; C F Ramos-Filho; O da R Santos; M P De Oliveira; M Halpern; C A Gouvea; M Schechter
Journal:  Genitourin Med       Date:  1994-02

8.  Voiding dysfunction in human immunodeficiency virus infections.

Authors:  C J Kane; D M Bolton; J A Connolly; E A Tanagho
Journal:  J Urol       Date:  1996-02       Impact factor: 7.450

9.  Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior.

Authors:  R O Roberts; T Rhodes; L A Panser; C J Girman; C G Chute; J E Oesterling; M M Lieber; S J Jacobsen
Journal:  Urology       Date:  1994-05       Impact factor: 2.649

10.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18
View more
  10 in total

1.  Geriatric Syndromes in Older HIV-Infected Adults.

Authors:  Meredith Greene; Kenneth E Covinsky; Victor Valcour; Yinghui Miao; Joy Madamba; Harry Lampiris; Irena Stijacic Cenzer; Jeffrey Martin; Steven G Deeks
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

2.  A Behavioral Weight Loss Program and Nonurinary Incontinence Lower Urinary Tract Symptoms in Overweight and Obese Women with Urinary Incontinence: A Secondary Data Analysis of PRIDE.

Authors:  Benjamin N Breyer; Jennifer M Creasman; Holly E Richter; Deborah Myers; Kathryn L Burgio; Rena R Wing; Delia Smith West; John W Kusek; Leslee L Subak
Journal:  J Urol       Date:  2017-08-12       Impact factor: 7.450

3.  Do adult men with untreated hypospadias have adverse outcomes? A pilot study using a social media advertised survey.

Authors:  Bruce Schlomer; Benjamin Breyer; Hillary Copp; Laurence Baskin; Michael DiSandro
Journal:  J Pediatr Urol       Date:  2014-02-24       Impact factor: 1.830

4.  Urinary symptoms and quality of life in women living with HIV: a cross-sectional study.

Authors:  Maryse Larouche; Arianne Y K Albert; Nancy Lipsky; Sharon Walmsley; Mona Loutfy; Fiona Smaill; Sylvie Trottier; Ari Bitnun; Mark H Yudin; Geoffrey W Cundiff; Deborah M Money
Journal:  Int Urogynecol J       Date:  2020-05-22       Impact factor: 2.894

5.  Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men.

Authors:  Benjamin N Breyer; Eric Vittinghoff; Stephen K Van Den Eeden; Bradley A Erickson; Alan W Shindel
Journal:  Urology       Date:  2011-10-02       Impact factor: 2.649

6.  Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.

Authors:  Soon Ok Lee; Jeong Eun Lee; Shinwon Lee; Sun Hee Lee; Jin Suk Kang; Hyunjin Son; Hyungi Lee; Jinmi Kim
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

Review 7.  Urological aspects of HIV and AIDS.

Authors:  Chris F Heyns; Shaun G Smit; André van der Merwe; Amir D Zarrabi
Journal:  Nat Rev Urol       Date:  2013-10-29       Impact factor: 14.432

8.  Paucisymptomatic infectious prostatitis as a cause of fever without an apparent origin. A series of 19 patients.

Authors:  I Novo-Veleiro; M Hernández-Cabrera; F Cañas-Hernández; E Pisos-Álamo; A Francés-Urmeneta; M Delgado-Yagüe; L Alvela-Suárez; J-L Pérez-Arellano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-06       Impact factor: 3.267

9.  Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study.

Authors:  Ly Hoang Roberts; Bernadette M M Zwaans; Kenneth M Peters; Michael Chancellor; Priya Padmanabhan
Journal:  Eur Urol Open Sci       Date:  2022-10-12

10.  Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia.

Authors:  A A Madigan; K M Sobek; J L Cummings; W R Green; D J Bacich; D S O'Keefe
Journal:  Genes Immun       Date:  2012-09-06       Impact factor: 2.676

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.